{
    "body": "List the different subtypes of thyroid cancer.", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17985985", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20969692", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21169742", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21553140", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8608779", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21272686", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24163390"
    ], 
    "ideal_answer": [
        "The different histologic subtypes of thyroid cancer include papillary, follicular, anaplastic, medullary, and H\u00fcrthle cell carcinomas."
    ], 
    "exact_answer": [
        [
            "Papillary thyroid carcinoma"
        ], 
        [
            "Follicular thyroid carcinoma"
        ], 
        [
            "Anaplastic thyroid carcinoma"
        ], 
        [
            "Medullary thyroid carcinoma"
        ], 
        [
            "H\u00fcrthle cell carcinoma"
        ]
    ], 
    "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:1781"
    ], 
    "type": "list", 
    "id": "5503145ee9bde69634000022", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 458, 
            "text": "Thyroid cancer is the most common cancer of the endocrine system and is responsible for the majority of deaths from endocrine malignancies. Although a large proportion of thyroid cancers belong to well differentiated histologic subtypes, which in general show a good prognosis after surgery and radioiodine ablation, the treatment of radio-resistant papillary-type, of undifferentiated anaplastic, and of medullary-type thyroid cancers remains unsatisfactory", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24163390", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 966, 
            "offsetInEndSection": 1090, 
            "text": "Supervised hierarchical cluster analysis demonstrated grouping of 2 histologies (papillary and follicular thyroid carcinoma)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21553140", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 747, 
            "offsetInEndSection": 1199, 
            "text": "FDG-PET/CT is also useful in the initial (post thyroidectomy) staging of high-risk patients with less differentiated (and thus less iodine-avid and clinically more aggressive) subtypes, such as tall cell variant and H\u00fcrthle cell carcinoma, but in particular poorly differentiated and anaplastic carcinoma. FDG-PET/CT may help in defining the extent of disease in some patients with medullary thyroid carcinoma and rising postoperative calcitonin levels", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21272686", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 268, 
            "offsetInEndSection": 399, 
            "text": "Histologic subtypes included papillary (41%), follicular (22%), anaplastic (19%), medullary (15%), and H\u00fcrthle cell carcinomas (4%)", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17985985", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 80, 
            "text": "Follicular thyroid cancer is the second most common thyroid malignancy after PTC", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8608779", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1151, 
            "offsetInEndSection": 1307, 
            "text": "Thyroid cancer subtypes were 90 patients with papillary thyroid cancer PTC, 24 with follicular FTC, eight with medullary MTC and two with anaplastic cancer.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20969692", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 72, 
            "text": "Papillary thyroid carcinoma is the most common type of thyroid malignancy", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169742", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 608, 
            "offsetInEndSection": 1027, 
            "text": "The main objectives of this review article are to (1) summarize the gross and histopathologic features of papillary thyroid carcinoma; (2) provide an overview of the subtypes of papillary thyroid carcinoma and their prognosis; (3) discuss established and emerging data on the immunohistochemical findings that are helpful in differential diagnosis; and (4) summarize molecular findings and pathogenesis of these lesions", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169742", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 247, 
            "offsetInEndSection": 413, 
            "text": "Although the vast majority of papillary thyroid carcinomas have an excellent prognosis, some variants of papillary thyroid carcinoma can have a more aggressive course", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21169742", 
            "endSection": "abstract"
        }
    ]
}